Gene symbol: Adcyap1

Also known as: Pacap

Organism: Rattus norvegicus

Summary: Enables neuropeptide hormone activity; pituitary adenylate cyclase activating polypeptide activity; and pituitary adenylate cyclase-activating polypeptide receptor binding activity. Involved in several processes, including negative regulation of acute inflammatory response; positive regulation of cell communication; and regulation of GTPase activity. Located in extracellular space and terminal bouton. Used to study Parkinsonism and acute necrotizing pancreatitis. Biomarker of cystitis. Orthologous to human ADCYAP1 (adenylate cyclase activating polypeptide 1). [provided by Alliance of Genome Resources, Apr 2022]

NCBI gene ID: 24166 Ensembl:ENSRNOG00000049882 AllianceGenome:RGD:2037


GO Annotation


Category Term ID Term description
Process GO:0000003 Reproduction
Process GO:0001541 Ovarian follicle development
Process GO:0001662 Behavioral fear response
Process GO:0001817 Regulation of cytokine production
Process GO:0001819 Positive regulation of cytokine production
Process GO:0001821 Histamine secretion
Process GO:0001932 Regulation of protein phosphorylation
Process GO:0001934 Positive regulation of protein phosphorylation
Process GO:0002209 Behavioral defense response
Process GO:0002673 Regulation of acute inflammatory response
Process GO:0002674 Negative regulation of acute inflammatory response
Process GO:0002682 Regulation of immune system process
Process GO:0002683 Negative regulation of immune system process
Process GO:0002790 Peptide secretion
Process GO:0002791 Regulation of peptide secretion
Process GO:0002793 Positive regulation of peptide secretion
Process GO:0002861 Regulation of inflammatory response to antigenic stimulus
Process GO:0002862 Negative regulation of inflammatory response to antigenic stimulus
Process GO:0002864 Regulation of acute inflammatory response to antigenic stimulus
Process GO:0002865 Negative regulation of acute inflammatory response to antigenic stimulus
Process GO:0002877 Regulation of acute inflammatory response to non-antigenic stimulus
Process GO:0002878 Negative regulation of acute inflammatory response to non-antigenic stimulus
Process GO:0003006 Developmental process involved in reproduction
Process GO:0003008 System process
Process GO:0003013 Circulatory system process
Process GO:0003018 Vascular process in circulatory system
Process GO:0006139 Nucleobase-containing compound metabolic process
Process GO:0006163 Purine nucleotide metabolic process
Process GO:0006355 Regulation of transcription, DNA-templated
Process GO:0006357 Regulation of transcription by RNA polymerase II
Process GO:0006725 Cellular aromatic compound metabolic process
Process GO:0006753 Nucleoside phosphate metabolic process
Process GO:0006793 Phosphorus metabolic process
Process GO:0006796 Phosphate-containing compound metabolic process
Process GO:0006807 Nitrogen compound metabolic process
Process GO:0006810 Transport
Process GO:0006811 Ion transport
Process GO:0006812 Cation transport
Process GO:0006950 Response to stress
Process GO:0006952 Defense response
Process GO:0007154 Cell communication
Process GO:0007165 Signal transduction
Process GO:0007186 G protein-coupled receptor signaling pathway
Process GO:0007188 Adenylate cyclase-modulating G protein-coupled receptor signaling pathway
Process GO:0007189 Adenylate cyclase-activating G protein-coupled receptor signaling pathway
Process GO:0007204 Positive regulation of cytosolic calcium ion concentration
Process GO:0007218 Neuropeptide signaling pathway
Process GO:0007267 Cell-cell signaling
Process GO:0007275 Multicellular organism development
Process GO:0007399 Nervous system development
Process GO:0007417 Central nervous system development
Process GO:0007420 Brain development
Process GO:0007548 Sex differentiation
Process GO:0007600 Sensory perception
Process GO:0007610 Behavior
Process GO:0008015 Blood circulation
Process GO:0008104 Protein localization
Process GO:0008152 Metabolic process
Process GO:0008277 Regulation of G protein-coupled receptor signaling pathway
Process GO:0008284 Positive regulation of cell population proliferation
Process GO:0008285 Negative regulation of cell population proliferation
Process GO:0008406 Gonad development
Process GO:0008585 Female gonad development
Process GO:0009117 Nucleotide metabolic process
Process GO:0009141 Nucleoside triphosphate metabolic process
Process GO:0009144 Purine nucleoside triphosphate metabolic process
Process GO:0009150 Purine ribonucleotide metabolic process
Process GO:0009199 Ribonucleoside triphosphate metabolic process
Process GO:0009205 Purine ribonucleoside triphosphate metabolic process
Process GO:0009259 Ribonucleotide metabolic process
Process GO:0009306 Protein secretion
Process GO:0009605 Response to external stimulus
Process GO:0009719 Response to endogenous stimulus
Process GO:0009725 Response to hormone
Process GO:0009889 Regulation of biosynthetic process
Process GO:0009891 Positive regulation of biosynthetic process
Process GO:0009893 Positive regulation of metabolic process
Process GO:0009914 Hormone transport
Process GO:0009966 Regulation of signal transduction
Process GO:0009967 Positive regulation of signal transduction
Process GO:0009987 Cellular process
Process GO:0009991 Response to extracellular stimulus
Process GO:0010033 Response to organic substance
Process GO:0010468 Regulation of gene expression
Process GO:0010556 Regulation of macromolecule biosynthetic process
Process GO:0010557 Positive regulation of macromolecule biosynthetic process
Process GO:0010562 Positive regulation of phosphorus metabolic process
Process GO:0010604 Positive regulation of macromolecule metabolic process
Process GO:0010628 Positive regulation of gene expression
Process GO:0010646 Regulation of cell communication
Process GO:0010647 Positive regulation of cell communication
Process GO:0010656 Negative regulation of muscle cell apoptotic process
Process GO:0010660 Regulation of muscle cell apoptotic process
Process GO:0010721 Negative regulation of cell development
Process GO:0010817 Regulation of hormone levels
Process GO:0010941 Regulation of cell death
Process GO:0010959 Regulation of metal ion transport
Process GO:0010975 Regulation of neuron projection development
Process GO:0010976 Positive regulation of neuron projection development
Process GO:0014013 Regulation of gliogenesis
Process GO:0014014 Negative regulation of gliogenesis
Process GO:0014070 Response to organic cyclic compound
Process GO:0015031 Protein transport
Process GO:0015833 Peptide transport
Process GO:0016043 Cellular component organization
Process GO:0019219 Regulation of nucleobase-containing compound metabolic process
Process GO:0019220 Regulation of phosphate metabolic process
Process GO:0019222 Regulation of metabolic process
Process GO:0019233 Sensory perception of pain
Process GO:0019637 Organophosphate metabolic process
Process GO:0019693 Ribose phosphate metabolic process
Process GO:0019932 Second-messenger-mediated signaling
Process GO:0019933 cAMP-mediated signaling
Process GO:0019935 Cyclic-nucleotide-mediated signaling
Process GO:0021536 Diencephalon development
Process GO:0021983 Pituitary gland development
Process GO:0022008 Neurogenesis
Process GO:0022414 Reproductive process
Process GO:0023051 Regulation of signaling
Process GO:0023052 Signaling
Process GO:0023056 Positive regulation of signaling
Process GO:0023061 Signal release
Process GO:0030030 Cell projection organization
Process GO:0030072 Peptide hormone secretion
Process GO:0030073 Insulin secretion
Process GO:0030154 Cell differentiation
Process GO:0030182 Neuron differentiation
Process GO:0030900 Forebrain development
Process GO:0031175 Neuron projection development
Process GO:0031323 Regulation of cellular metabolic process
Process GO:0031325 Positive regulation of cellular metabolic process
Process GO:0031326 Regulation of cellular biosynthetic process
Process GO:0031328 Positive regulation of cellular biosynthetic process
Process GO:0031344 Regulation of cell projection organization
Process GO:0031346 Positive regulation of cell projection organization
Process GO:0031347 Regulation of defense response
Process GO:0031348 Negative regulation of defense response
Process GO:0031399 Regulation of protein modification process
Process GO:0031401 Positive regulation of protein modification process
Process GO:0031667 Response to nutrient levels
Process GO:0031960 Response to corticosteroid
Process GO:0032101 Regulation of response to external stimulus
Process GO:0032102 Negative regulation of response to external stimulus
Process GO:0032501 Multicellular organismal process
Process GO:0032502 Developmental process
Process GO:0032642 Regulation of chemokine production
Process GO:0032675 Regulation of interleukin-6 production
Process GO:0032722 Positive regulation of chemokine production
Process GO:0032755 Positive regulation of interleukin-6 production
Process GO:0032870 Cellular response to hormone stimulus
Process GO:0032879 Regulation of localization
Process GO:0032880 Regulation of protein localization
Process GO:0032940 Secretion by cell
Process GO:0033036 Macromolecule localization
Process GO:0033555 Multicellular organismal response to stress
Process GO:0033674 Positive regulation of kinase activity
Process GO:0033993 Response to lipid
Process GO:0034260 Negative regulation of GTPase activity
Process GO:0034641 Cellular nitrogen compound metabolic process
Process GO:0035150 Regulation of tube size
Process GO:0035270 Endocrine system development
Process GO:0035296 Regulation of tube diameter
Process GO:0035556 Intracellular signal transduction
Process GO:0035592 Establishment of protein localization to extracellular region
Process GO:0042127 Regulation of cell population proliferation
Process GO:0042221 Response to chemical
Process GO:0042311 Vasodilation
Process GO:0042325 Regulation of phosphorylation
Process GO:0042327 Positive regulation of phosphorylation
Process GO:0042391 Regulation of membrane potential
Process GO:0042594 Response to starvation
Process GO:0042596 Fear response
Process GO:0042886 Amide transport
Process GO:0042981 Regulation of apoptotic process
Process GO:0043066 Negative regulation of apoptotic process
Process GO:0043067 Regulation of programmed cell death
Process GO:0043069 Negative regulation of programmed cell death
Process GO:0043085 Positive regulation of catalytic activity
Process GO:0043086 Negative regulation of catalytic activity
Process GO:0043087 Regulation of GTPase activity
Process GO:0043266 Regulation of potassium ion transport
Process GO:0043267 Negative regulation of potassium ion transport
Process GO:0043269 Regulation of ion transport
Process GO:0043271 Negative regulation of ion transport
Process GO:0043408 Regulation of MAPK cascade
Process GO:0043410 Positive regulation of MAPK cascade
Process GO:0043547 Positive regulation of GTPase activity
Process GO:0043549 Regulation of kinase activity
Process GO:0043949 Regulation of cAMP-mediated signaling
Process GO:0043950 Positive regulation of cAMP-mediated signaling
Process GO:0044092 Negative regulation of molecular function
Process GO:0044093 Positive regulation of molecular function
Process GO:0044237 Cellular metabolic process
Process GO:0044238 Primary metabolic process
Process GO:0044281 Small molecule metabolic process
Process GO:0045137 Development of primary sexual characteristics
Process GO:0045184 Establishment of protein localization
Process GO:0045471 Response to ethanol
Process GO:0045595 Regulation of cell differentiation
Process GO:0045596 Negative regulation of cell differentiation
Process GO:0045786 Negative regulation of cell cycle
Process GO:0045859 Regulation of protein kinase activity
Process GO:0045860 Positive regulation of protein kinase activity
Process GO:0045893 Positive regulation of transcription, DNA-templated
Process GO:0045935 Positive regulation of nucleobase-containing compound metabolic process
Process GO:0045937 Positive regulation of phosphate metabolic process
Process GO:0045944 Positive regulation of transcription by RNA polymerase II
Process GO:0046034 ATP metabolic process
Process GO:0046483 Heterocycle metabolic process
Process GO:0046545 Development of primary female sexual characteristics
Process GO:0046660 Female sex differentiation
Process GO:0046879 Hormone secretion
Process GO:0046883 Regulation of hormone secretion
Process GO:0046887 Positive regulation of hormone secretion
Process GO:0046903 Secretion
Process GO:0048468 Cell development
Process GO:0048513 Animal organ development
Process GO:0048518 Positive regulation of biological process
Process GO:0048519 Negative regulation of biological process
Process GO:0048522 Positive regulation of cellular process
Process GO:0048523 Negative regulation of cellular process
Process GO:0048545 Response to steroid hormone
Process GO:0048583 Regulation of response to stimulus
Process GO:0048584 Positive regulation of response to stimulus
Process GO:0048585 Negative regulation of response to stimulus
Process GO:0048608 Reproductive structure development
Process GO:0048666 Neuron development
Process GO:0048699 Generation of neurons
Process GO:0048731 System development
Process GO:0048732 Gland development
Process GO:0048856 Anatomical structure development
Process GO:0048869 Cellular developmental process
Process GO:0050727 Regulation of inflammatory response
Process GO:0050728 Negative regulation of inflammatory response
Process GO:0050767 Regulation of neurogenesis
Process GO:0050768 Negative regulation of neurogenesis
Process GO:0050776 Regulation of immune response
Process GO:0050777 Negative regulation of immune response
Process GO:0050789 Regulation of biological process
Process GO:0050790 Regulation of catalytic activity
Process GO:0050793 Regulation of developmental process
Process GO:0050794 Regulation of cellular process
Process GO:0050804 Modulation of chemical synaptic transmission
Process GO:0050806 Positive regulation of synaptic transmission
Process GO:0050877 Nervous system process
Process GO:0050896 Response to stimulus
Process GO:0051046 Regulation of secretion
Process GO:0051047 Positive regulation of secretion
Process GO:0051049 Regulation of transport
Process GO:0051050 Positive regulation of transport
Process GO:0051051 Negative regulation of transport
Process GO:0051093 Negative regulation of developmental process
Process GO:0051128 Regulation of cellular component organization
Process GO:0051130 Positive regulation of cellular component organization
Process GO:0051171 Regulation of nitrogen compound metabolic process
Process GO:0051173 Positive regulation of nitrogen compound metabolic process
Process GO:0051174 Regulation of phosphorus metabolic process
Process GO:0051179 Localization
Process GO:0051234 Establishment of localization
Process GO:0051239 Regulation of multicellular organismal process
Process GO:0051240 Positive regulation of multicellular organismal process
Process GO:0051241 Negative regulation of multicellular organismal process
Process GO:0051246 Regulation of protein metabolic process
Process GO:0051247 Positive regulation of protein metabolic process
Process GO:0051252 Regulation of RNA metabolic process
Process GO:0051254 Positive regulation of RNA metabolic process
Process GO:0051336 Regulation of hydrolase activity
Process GO:0051338 Regulation of transferase activity
Process GO:0051345 Positive regulation of hydrolase activity
Process GO:0051346 Negative regulation of hydrolase activity
Process GO:0051347 Positive regulation of transferase activity
Process GO:0051384 Response to glucocorticoid
Process GO:0051608 Histamine transport
Process GO:0051641 Cellular localization
Process GO:0051716 Cellular response to stimulus
Process GO:0051726 Regulation of cell cycle
Process GO:0051960 Regulation of nervous system development
Process GO:0051961 Negative regulation of nervous system development
Process GO:0051966 Regulation of synaptic transmission, glutamatergic
Process GO:0051968 Positive regulation of synaptic transmission, glutamatergic
Process GO:0055086 Nucleobase-containing small molecule metabolic process
Process GO:0060078 Regulation of postsynaptic membrane potential
Process GO:0060123 Regulation of growth hormone secretion
Process GO:0060124 Positive regulation of growth hormone secretion
Process GO:0060251 Regulation of glial cell proliferation
Process GO:0060253 Negative regulation of glial cell proliferation
Process GO:0060255 Regulation of macromolecule metabolic process
Process GO:0060284 Regulation of cell development
Process GO:0060322 Head development
Process GO:0060341 Regulation of cellular localization
Process GO:0060548 Negative regulation of cell death
Process GO:0061458 Reproductive system development
Process GO:0065007 Biological regulation
Process GO:0065008 Regulation of biological quality
Process GO:0065009 Regulation of molecular function
Process GO:0070372 Regulation of ERK1 and ERK2 cascade
Process GO:0070374 Positive regulation of ERK1 and ERK2 cascade
Process GO:0070445 Regulation of oligodendrocyte progenitor proliferation
Process GO:0070727 Cellular macromolecule localization
Process GO:0070887 Cellular response to chemical stimulus
Process GO:0071310 Cellular response to organic substance
Process GO:0071383 Cellular response to steroid hormone stimulus
Process GO:0071384 Cellular response to corticosteroid stimulus
Process GO:0071385 Cellular response to glucocorticoid stimulus
Process GO:0071396 Cellular response to lipid
Process GO:0071407 Cellular response to organic cyclic compound
Process GO:0071495 Cellular response to endogenous stimulus
Process GO:0071649 Regulation of chemokine (C-C motif) ligand 5 production
Process GO:0071651 Positive regulation of chemokine (C-C motif) ligand 5 production
Process GO:0071692 Protein localization to extracellular region
Process GO:0071702 Organic substance transport
Process GO:0071704 Organic substance metabolic process
Process GO:0071705 Nitrogen compound transport
Process GO:0071840 Cellular component organization or biogenesis
Process GO:0072521 Purine-containing compound metabolic process
Process GO:0080090 Regulation of primary metabolic process
Process GO:0080134 Regulation of response to stress
Process GO:0090066 Regulation of anatomical structure size
Process GO:0090087 Regulation of peptide transport
Process GO:0090273 Regulation of somatostatin secretion
Process GO:0090274 Positive regulation of somatostatin secretion
Process GO:0090276 Regulation of peptide hormone secretion
Process GO:0090277 Positive regulation of peptide hormone secretion
Process GO:0097305 Response to alcohol
Process GO:0097746 Blood vessel diameter maintenance
Process GO:0099177 Regulation of trans-synaptic signaling
Process GO:0120035 Regulation of plasma membrane bounded cell projection organization
Process GO:0120036 Plasma membrane bounded cell projection organization
Process GO:0120161 Regulation of cold-induced thermogenesis
Process GO:0120162 Positive regulation of cold-induced thermogenesis
Process GO:0140352 Export from cell
Process GO:1901135 Carbohydrate derivative metabolic process
Process GO:1901360 Organic cyclic compound metabolic process
Process GO:1901564 Organonitrogen compound metabolic process
Process GO:1901700 Response to oxygen-containing compound
Process GO:1902531 Regulation of intracellular signal transduction
Process GO:1902533 Positive regulation of intracellular signal transduction
Process GO:1902680 Positive regulation of RNA biosynthetic process
Process GO:1903506 Regulation of nucleic acid-templated transcription
Process GO:1903508 Positive regulation of nucleic acid-templated transcription
Process GO:1903530 Regulation of secretion by cell
Process GO:1903532 Positive regulation of secretion by cell
Process GO:2000026 Regulation of multicellular organismal development
Process GO:2000177 Regulation of neural precursor cell proliferation
Process GO:2001141 Regulation of RNA biosynthetic process
Component GO:0005576 Extracellular region
Component GO:0005615 Extracellular space
Component GO:0005622 Intracellular anatomical structure
Component GO:0005737 Cytoplasm
Component GO:0005829 Cytosol
Component GO:0030054 Cell junction
Component GO:0030424 Axon
Component GO:0036477 Somatodendritic compartment
Component GO:0042995 Cell projection
Component GO:0043005 Neuron projection
Component GO:0043025 Neuronal cell body
Component GO:0043195 Terminal bouton
Component GO:0043204 Perikaryon
Component GO:0043679 Axon terminus
Component GO:0044297 Cell body
Component GO:0044306 Neuron projection terminus
Component GO:0045202 Synapse
Component GO:0098793 Presynapse
Component GO:0110165 Cellular anatomical entity
Component GO:0120025 Plasma membrane bounded cell projection
Component GO:0150034 Distal axon
Function GO:0001664 G protein-coupled receptor binding
Function GO:0005102 Signaling receptor binding
Function GO:0005179 Hormone activity
Function GO:0005184 Neuropeptide hormone activity
Function GO:0005488 Binding
Function GO:0005515 Protein binding
Function GO:0016521 Pituitary adenylate cyclase activating polypeptide activity
Function GO:0030545 Signaling receptor regulator activity
Function GO:0030546 Signaling receptor activator activity
Function GO:0031858 Pituitary adenylate cyclase-activating polypeptide receptor binding
Function GO:0048018 Receptor ligand activity
Function GO:0051427 Hormone receptor binding
Function GO:0051428 Peptide hormone receptor binding
Function GO:0071855 Neuropeptide receptor binding
Function GO:0098772 Molecular function regulator activity

Pathway annotation


Category Term ID Term description
RCTM RNO-162582 Signal Transduction
RCTM RNO-372790 Signaling by GPCR
RCTM RNO-373080 Class B/2 (Secretin family receptors)
RCTM RNO-420092 Glucagon-type ligand receptors
RCTM RNO-500792 GPCR ligand binding
KEGG rno04024 cAMP signaling pathway
KEGG rno04080 Neuroactive ligand-receptor interaction
KEGG rno04713 Circadian entrainment
KEGG rno04911 Insulin secretion
KEGG rno04924 Renin secretion

Expression profile of Adcyap1 in omics data



ID GSE100499
Title Exploring acupuncture mechanism in preconditioning of IRI
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM2685201 MX1 tissue: Myocardium gender: male 5.088927
GSM2685202 MX2 tissue: Myocardium gender: female 5.417182
GSM2685203 MX3 tissue: Myocardium gender: female 5.3698063
GSM2685204 MX4 tissue: Myocardium gender: male 5.602184
GSM2685205 DZ1 tissue: Myocardium gender: male 5.5635324
GSM2685206 DZ2 tissue: Myocardium gender: male 5.41153
GSM2685207 DZ3 tissue: Myocardium gender: female 5.46606
GSM2685208 DZ4 tissue: Myocardium gender: female 5.38955
GSM2685209 JJ1 tissue: Myocardium gender: male 5.036479
GSM2685210 JJ2 tissue: Myocardium gender: female 5.4048223
GSM2685211 JJ3 tissue: Myocardium gender: female 5.582539
GSM2685212 JJ4 tissue: Myocardium gender: male 5.7668247
GSM2685213 NG1 tissue: Myocardium gender: male 5.5847626
GSM2685214 NG2 tissue: Myocardium gender: female 4.979766
GSM2685215 NG3 tissue: Myocardium gender: male 5.3015404
GSM2685216 NG4 tissue: Myocardium gender: female 5.5502853
GSM2685217 YL1 tissue: Myocardium gender: male 4.637957
GSM2685218 YL2 tissue: Myocardium gender: male 4.3516073
GSM2685219 YL3 tissue: Myocardium gender: female 3.711938
GSM2685220 YL4 tissue: Myocardium gender: female 4.527612
GSM2685221 QC1 tissue: Myocardium gender: male 5.3392057
GSM2685222 QC2 tissue: Myocardium gender: male 5.7533092
GSM2685223 QC3 tissue: Myocardium gender: female 5.381226
GSM2685224 QC4 tissue: Myocardium gender: female 6.0037484

ID GSE136833
Title Effects of lidocaine on the expression of rat spinal cord
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4058984 Control_1 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 4.922835578
GSM4058985 Control_2 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 5.264427771
GSM4058986 Control_3 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 4.825354395
GSM4058987 Lidocaine_1 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 5.013726867
GSM4058988 Lidocaine_2 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 5.26748529
GSM4058989 Lidocaine_3 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 4.819905456

ID GSE138454
Title Impact of inflammation on hepatic subcellular energetics in anesthetized rats
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4108997 Sample 1 Isoflurane sepsis anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 0.0
GSM4108998 Sample 2 Isoflurane sepsis anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 1.0
GSM4108999 Sample 3 Isoflurane sepsis anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 0.0
GSM4109000 Sample 4 Isoflurane sepsis anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 0.0
GSM4109001 Sample 5 Isoflurane control anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 0.0
GSM4109002 Sample 6 Isoflurane control anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 2.0
GSM4109003 Sample 7 Isoflurane control anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 1.0
GSM4109004 Sample 8 Isoflurane control anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 0.0
GSM4109005 Sample9 Propofol sepsis anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 2.0
GSM4109006 Sample10 Propofol sepsis anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 1.0
GSM4109007 Sample11 Propofol sepsis anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 0.0
GSM4109008 Sample12 Propofol sepsis anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 2.0
GSM4109009 Sample13 Propofol control anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 0.0
GSM4109010 Sample14 Propofol control anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 0.0
GSM4109011 Sample 15 Propofol control anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 1.0
GSM4109012 Sample16 Propofol control anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 0.0

ID GSE139220
Title Expression data from sevoflurane anesthesia treated rat
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4134285 Brain_Control_rep1 strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus 6.15715
GSM4134286 Brain_Control_rep2 strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus 6.8262
GSM4134287 Brain_Control_rep3 strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus 6.778869
GSM4134288 Brain_Sevoflurane_rep1 strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus 6.353642
GSM4134289 Brain_Sevoflurane_rep2 strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus 6.779524
GSM4134290 Brain_Sevoflurane_rep3 strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus 6.633186

ID GSE143895
Title GPR160 de-orphanization reveals critical roles in neuropathic pain in rodents
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4276356 dhsc01 strain: Sprague Dawley tissue: DHSC treatment: CCI 13.388
GSM4276357 dhsc03 strain: Sprague Dawley tissue: DHSC treatment: CCI 19.075
GSM4276358 dhsc05 strain: Sprague Dawley tissue: DHSC treatment: CCI 17.532
GSM4276359 dhsc13 strain: Sprague Dawley tissue: DHSC treatment: SHAM 9.039
GSM4276360 dhsc15 strain: Sprague Dawley tissue: DHSC treatment: SHAM 14.139

ID GSE157924
Title Regulation of acupuncture on genes in brain stem
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4780973 Rattus_JSSZ(Sham) tissue: Rattus brainstem of modeling treatment: Sham 8.491734708500001
GSM4780974 Rattus_JXZ(Hand Acu) tissue: Rattus brainstem of modeling treatment: Hand Acu 8.6854629785
GSM4780975 Rattus_MXZ(TBI) tissue: Rattus brainstem of modeling treatment: TBI 8.5852476255

ID GSE1616
Title Genomics of preconditioning
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM27484 APC_a (anesthetic-preconditioning, 1st replicate) 92.86666666666667
GSM27485 APC_b (anesthetic-preconditioning, 2nd replicate) 51.13333333333333
GSM27486 APC_c (anesthetic-preconditioning, 3rd replicate) 79.23333333333333
GSM27487 APC_d (anesthetic-preconditioning, 4th replicate) 81.66666666666667
GSM27488 APC_e (anesthetic-preconditioning, 5th replicate) 55.633333333333326
GSM27489 APC_TRI_a (trigger of anesthetic-preconditioning, 1st replicate) 97.93333333333334
GSM27490 APC_TRI_b (trigger of anesthetic-preconditioning, 2nd replicate) 139.9333333333333
GSM27491 APC_TRI_c (trigger of anesthetic-preconditioning, 3rd replicate) 74.23333333333333
GSM27492 APC_TRI_d (trigger of anesthetic-preconditioning, 4th replicate) 140.5666666666667
GSM27493 APC_TRI_e (trigger of anesthetic-preconditioning, 5th replicate) 114.0
GSM27494 CTL_a (control, 1st replicate) 83.63333333333334
GSM27495 CTL_b (control, 2nd replicate) 63.73333333333334
GSM27496 CTL_c (control, 3rd replicate) 75.76666666666667
GSM27497 CTL_d (control, 4th replicate) 68.2
GSM27498 CTL_e (control, 5th replicate) 70.06666666666668
GSM27499 IPC_a (ischemic preconditioning, 1st replicate) 65.93333333333334
GSM27500 IPC_b (ischemic preconditioning, 2nd replicate) 68.76666666666667
GSM27501 IPC_c (ischemic preconditioning, 3rd replicate) 49.03333333333333
GSM27502 IPC_d (ischemic preconditioning, 4th replicate) 49.9
GSM27503 IPC_e (ischemic preconditioning, 5th replicate) 69.33333333333333
GSM27504 IPC_TRI_a (trigger of ischemic preconditioning, 1st replicate) 132.7
GSM27505 IPC_TRI_b (trigger of ischemic preconditioning, 2nd replicate) 176.16666666666666
GSM27506 IPC_TRI_c (trigger of ischemic preconditioning, 3rd replicate) 70.8
GSM27507 IPC_TRI_d (trigger of ischemic preconditioning, 4th replicate) 108.43333333333334
GSM27508 IPC_TRI_e (trigger of ischemic preconditioning, 5th replicate) 206.26666666666665
GSM27509 ISCH_a (ischemia, 1st replicate) 90.93333333333334
GSM27510 ISCH_b (ischemia, 2nd replicate) 57.73333333333334
GSM27511 ISCH_c (ischemia, 3rd replicate) 88.56666666666666
GSM27512 ISCH_d (ischemia, 4th replicate) 89.86666666666667
GSM27513 ISCH_e (ischemia, 5th replicate) 96.2

ID GSE1779
Title Effect of Isoflurane and LTM on basolateral amygdala
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM30790 baseline control 01 male, 275-300g 442.4
GSM30791 baseline control 02 male, 275-300g 757.2
GSM30792 baseline control 03 male, 275-300g 759.2
GSM30793 baseline control 04 male, 275-300g 346.5
GSM30794 baseline control 05 male, 275-300g 416.3
GSM30795 baseline control 06 male, 275-300g 413.8
GSM30796 baseline control 07 male, 275-300g 374.0
GSM30797 baseline control 08 male, 275-300g 506.2
GSM30798 baseline control 09 male, 275-300g 123.1
GSM30799 pain 01 253.9
GSM30800 pain 02 364.9
GSM30801 pain 03 249.8
GSM30802 pain 04 511.5
GSM30803 pain 05 466.2
GSM30804 FC 01 369.5
GSM30805 FC 02 170.0
GSM30806 FC 03 223.2
GSM30807 FC 04 393.1
GSM30808 FC 05 229.8
GSM30809 IFC 01 395.1
GSM30810 IFC 02 446.4
GSM30811 IFC 03 351.3
GSM30812 IFC 04 385.0
GSM30813 IFC 05 481.2
GSM99800 isoflurane 01 male, 275-300g 403.1
GSM99801 isoflurane 02 male, 275-300g 454.9
GSM99802 isoflurane 03 male, 275-300g 499.4
GSM99803 isoflurane 04 male, 275-300g 318.9
GSM99804 isoflurane 05 male, 275-300g 530.2

ID GSE190472
Title Study on VEGF regulation mechanism of acupuncture improving endometrial receptivity in IVF-ET
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM5724271 model 21 Sex: female tissue: Uterine tissue condition: model 4.05945
GSM5724272 model 22 Sex: female tissue: Uterine tissue condition: model 3.48965
GSM5724273 model 23 Sex: female tissue: Uterine tissue condition: model 3.71955
GSM5724274 treatment31 Sex: female tissue: Uterine tissue condition: treatment 4.27655
GSM5724275 treatment32 Sex: female tissue: Uterine tissue condition: treatment 4.4259
GSM5724276 treatment33 Sex: female tissue: Uterine tissue condition: treatment 4.3652999999999995
GSM5724277 control 41 Sex: female tissue: Uterine tissue condition: control 4.0318
GSM5724278 control 42 Sex: female tissue: Uterine tissue condition: control 4.09915
GSM5724279 control 43 Sex: female tissue: Uterine tissue condition: control 3.6461

ID GSE192399
Title Gene expression of brain regions activated by sevoflurane and propofol
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM5746332 LHb, Sevoflurane, 60mins brain region: the lateral habenula (LHb) treatment: Sevoflurane 11.5162
GSM5746333 LHb, O2, 60mins brain region: the lateral habenula (LHb) treatment: O2 11.4942
GSM5746334 MHb, Sevoflurane, 60mins brain region: the medial habenula (MHb) treatment: Sevoflurane 11.7881
GSM5746335 MHb, O2, 60mins brain region: the medial habenula (MHb) treatment: O2 12.0866
GSM5746336 Sol, Sevoflurane, 60mins brain region: the solitary nucleus (Sol) treatment: Sevoflurane 12.7254
GSM5746337 Sol, O2, 60mins brain region: the solitary nucleus (Sol) treatment: O2 12.9645
GSM5746338 Mve, Sevoflurane, 60mins brain region: the medial vestibular nucleus (MVe) treatment: Sevoflurane 8.14478
GSM5746339 Mve, O2, 60mins brain region: the medial vestibular nucleus (MVe) treatment: O2 7.52827
GSM5746340 LHb, Propofol, 60mins brain region: the lateral habenula (LHb) treatment: Propofol 12.5759
GSM5746341 LHb, Intralipos, 60mins brain region: the lateral habenula (LHb) treatment: Intralipos 11.5502
GSM5746342 MHb, Propofol, 60mins brain region: the medial habenula (MHb) treatment: Propofol 12.087
GSM5746343 MHb, Intralipos, 60mins brain region: the medial habenula (MHb) treatment: Intralipos 11.9395
GSM5746344 Sol, Propofol, 60mins brain region: the solitary nucleus (Sol) treatment: Propofol 12.967
GSM5746345 Sol, Intralipos, 60mins brain region: the solitary nucleus (Sol) treatment: Intralipos 12.5155
GSM5746346 MVe, Propofol, 60mins brain region: the medial vestibular nucleus (MVe) treatment: Propofol 8.13789
GSM5746347 MVe, Intralipos, 60mins brain region: the medial vestibular nucleus (MVe) treatment: Intralipos 7.75608

ID GSE205202
Title Hepatic responses of mice and rats to equivalent acetaminophen (APAP) insult [rat]
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM6208507 Rat_Baseline_0h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 4.562333
GSM6208508 Rat_Baseline_0h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 4.579073
GSM6208509 Rat_Baseline_0h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 4.540485
GSM6208510 Rat_Baseline_0h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 4.586875
GSM6208511 Rat_Baseline_0h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 4.612496
GSM6208512 Rat_Vehicle_03h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 4.503547
GSM6208513 Rat_Vehicle_03h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 4.573791
GSM6208514 Rat_Vehicle_03h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 4.571377
GSM6208515 Rat_Vehicle_03h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 4.641115
GSM6208516 Rat_Vehicle_03h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 4.521702
GSM6208517 Rat_Vehicle_06h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 4.491775
GSM6208518 Rat_Vehicle_06h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 4.709945
GSM6208519 Rat_Vehicle_06h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 4.661754
GSM6208520 Rat_Vehicle_06h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 4.584518
GSM6208521 Rat_Vehicle_06h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 4.53751
GSM6208522 Rat_Vehicle_09h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 4.595896
GSM6208523 Rat_Vehicle_09h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 4.514445
GSM6208524 Rat_Vehicle_09h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 4.644987
GSM6208525 Rat_Vehicle_09h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 4.589868
GSM6208526 Rat_Vehicle_09h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 4.688394
GSM6208527 Rat_Vehicle_24h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 4.59705
GSM6208528 Rat_Vehicle_24h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 4.59705
GSM6208529 Rat_Vehicle_24h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 4.544639
GSM6208530 Rat_Vehicle_24h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 4.553
GSM6208531 Rat_Vehicle_24h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 4.600767
GSM6208532 Rat_APAP_03h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 4.557986
GSM6208533 Rat_APAP_03h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 4.730408
GSM6208534 Rat_APAP_03h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 4.533544
GSM6208535 Rat_APAP_03h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 4.623
GSM6208536 Rat_APAP_03h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 4.602894
GSM6208537 Rat_APAP_06h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 4.601829
GSM6208538 Rat_APAP_06h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 4.627445
GSM6208539 Rat_APAP_06h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 4.767265
GSM6208540 Rat_APAP_06h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 4.537796
GSM6208541 Rat_APAP_06h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 4.695042
GSM6208542 Rat_APAP_09h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 4.59705
GSM6208543 Rat_APAP_09h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 4.607935
GSM6208544 Rat_APAP_09h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 4.59705
GSM6208545 Rat_APAP_09h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 4.627385
GSM6208546 Rat_APAP_09h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 4.57537
GSM6208547 Rat_APAP_24h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 4.664792
GSM6208548 Rat_APAP_24h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 4.649397
GSM6208549 Rat_APAP_24h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 4.686997
GSM6208550 Rat_APAP_24h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 4.559614
GSM6208551 Rat_APAP_24h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 4.704103

ID GSE232804
Title EGR3 regulates opioid-related nociception and motivation in male rats
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM7383519 ww01_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Salin 88.0
GSM7383520 ww02_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 125.0
GSM7383521 ww03_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Salin 109.0
GSM7383522 ww05_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 106.0
GSM7383523 ww06_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Salin 107.0
GSM7383524 ww07_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 108.0
GSM7383525 ww08_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Salin 78.0
GSM7383526 ww10_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 72.0
GSM7383527 ww12_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 85.0
GSM7383528 ww13_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 113.0
GSM7383529 ww14_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 96.0
GSM7383530 ww15_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 110.0
GSM7383531 ww16_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 137.0
GSM7383532 ww17_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 116.0
GSM7383533 ww18_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 168.0
GSM7383534 ww20_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 77.0
GSM7383535 ww21_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 128.0
GSM7383536 ww22_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 98.0
GSM7383537 ww23_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 75.0
GSM7383538 ww24_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 84.0
GSM7383539 ww26_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 90.0
GSM7383540 ww27_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 150.0
GSM7383541 ww28_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 131.0
GSM7383542 ww30_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 117.0
GSM7383543 ww31_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 80.0
GSM7383544 ww32_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 86.0
GSM7383545 ww34_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 170.0
GSM7383546 ww35_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 93.0
GSM7383547 ww36_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 138.0
GSM7383548 ww37_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 107.0
GSM7383549 ww38_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 137.0
GSM7383550 www09_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 161.0
GSM7383551 www19_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 111.0
GSM7383552 www29_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 118.0
GSM7383553 www33_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 100.0
GSM7383554 www39_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 60.0

ID GSE244436
Title Similarity and dissimilarity in alteration of gene expression profile associated with inhalational anesthesia between sevoflurane and desflurane
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM7816143 Liver, Control for SevoAnes tissue: liver genotype: wild type treatment: Control for SevoAnes 0.0
GSM7816144 Liver, Anesthetized with sevoflurane for 6 h tissue: liver genotype: wild type treatment: Anesthetized with sevoflurane for 6 h 0.033301
GSM7816145 Liver, Control for DesAnes tissue: liver genotype: wild type treatment: Control for DesAnes 0.105111
GSM7816146 Liver, Anesthetized with desflurane for 6 h tissue: liver genotype: wild type treatment: Anesthetized with desflurane for 6 h 0.0

ID GSE2982
Title Effect of inhaled anesthetic to cultured cortical neurons
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM61779 Cell Culture Exposure (control1) Cy3 label;Cy5; 0.0127
GSM61796 Cell Culture Exposure (control2) Cy3; Cy5 0.0192
GSM61797 Cell Culture Exposure (control3) Cy3; Cy5 0.132
GSM61798 Cell Culture Exposure (1MAC Halo1) Cy3; Cy5 0.046
GSM61799 Cell Culture Exposure (1MAC Halo2) Cy3; Cy5 0.216
GSM61800 Cell Culture Exposure (1MAC Halo3) Cy3; Cy5 0.194
GSM61801 Cell Culture Exposure (3MAC Halo1) Cy3; Cy5 0.0559
GSM61802 Cell Culture Exposure (3MAC Halo2) Cy3; Cy5 0.022
GSM61803 Cell Culture Exposure (3MAC Halo3) Cy3; Cy5 0.0398
GSM61804 Cell Culture Exposure (3MAC ISO1) Cy3; Cy5 0.4
GSM61805 Cell Culture Exposure (3MAC ISO2) Cy3; Cy5 0.274
GSM61806 Cell Culture Exposure (3MAC ISO3) Cy3; Cy5 0.336

ID GSE359
Title Isoflurane Single Exposures
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM5120 Isoflurane single exposure control-1 100.23333333333333
GSM5121 Isoflurane single exposure control-2 115.16666666666667
GSM5122 Isoflurane single exposure control-3 38.06666666666667
GSM5124 Isoflurane single exposure 1 hr-1 65.3
GSM5126 Isoflurane single exposure 1 hr-2 98.93333333333334
GSM5127 Isoflurane single exposure 2 hr-1 97.0
GSM5130 Isoflurane single exposure 2 hr-2 79.13333333333334
GSM5131 Isoflurane single exposure 2 hr-3 66.46666666666665

ID GSE48025
Title Affymetrix Chip Data of the Transcriptome of the Rheumatoid Arthritis Rat Model Treated with Acupuncture (Affymetrix, mRNA, batch1)
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM1165929 RAT_NORA_T0_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy 3.051784749
GSM1165930 RAT_NORA_T0_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy 2.889991952
GSM1165931 RAT_RA_T0_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy 2.977884128
GSM1165932 RAT_RA_T0_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy 2.9248314215
GSM1165933 RAT_NORA_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy 2.921039984
GSM1165934 RAT_NORA_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy 3.0290862325
GSM1165935 RAT_AP_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy 3.3799351355000002
GSM1165936 RAT_AP_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy 2.9008793495000003
GSM1165937 RAT_MTX_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy 2.7825514165
GSM1165938 RAT_MTX_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy 2.8726837485
GSM1165939 RAT_ANE_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy 2.962507473
GSM1165940 RAT_ANE_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy 2.948767312
GSM1165941 RAT_PLA_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy 2.8206212204999996
GSM1165942 RAT_PLA_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy 3.0630996535
GSM1165943 RAT_NORA_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy 2.8739680859999996
GSM1165944 RAT_NORA_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy 2.8615072075
GSM1165945 RAT_AP_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy 2.901776211
GSM1165946 RAT_AP_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy 3.2026467629999997
GSM1165947 RAT_MTX_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy 3.0443306265
GSM1165948 RAT_MTX_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy 2.8969714189999998
GSM1165949 RAT_ANE_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy 2.9576251855000004
GSM1165950 RAT_ANE_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy 2.9980180195
GSM1165951 RAT_PLA_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy 2.9658086705
GSM1165952 RAT_PLA_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy 2.9666398195

ID GSE53897
Title Genome-wide analysis of dorsal root ganglion (DRG) gene expression after morphine or oxycodone treatment
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM1303240 DRG RVM1 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 9.859259
GSM1303241 DRG RVM2 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 9.700889
GSM1303242 DRG RVM3 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 10.040958
GSM1303243 DRG RVM7 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 9.72668
GSM1303244 DRG RVOx2 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 9.396596
GSM1303245 DRG RVOx3 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 10.009485
GSM1303246 DRG RVOx5 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 9.894432
GSM1303247 DRG RVOx7 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 9.983692
GSM1303248 DRG RVS4 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 10.033497
GSM1303249 DRG RVS5 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 9.697933
GSM1303250 DRG RVS6 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 9.714651
GSM1303251 DRG RVS7 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 9.937372
GSM1303252 DRG RSM1 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 9.470621
GSM1303253 DRG RSM2 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 9.692495
GSM1303254 DRG RSM4 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 9.661432
GSM1303255 DRG RSM5 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 9.686296
GSM1303256 DRG RSOx1 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 9.77625
GSM1303257 DRG RSOx2 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 9.733592
GSM1303258 DRG RSOx3 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 9.626619
GSM1303259 DRG RSOx4 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 9.548874
GSM1303260 DRG RSS1 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 9.585313
GSM1303261 DRG RSS2 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 9.937372
GSM1303262 DRG RSS3 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 9.62328
GSM1303263 DRG RSS6 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 9.882772

ID GSE55573
Title Using DNA microarray to screen intracellular signal pathways of hypoglycemic activity by electroacupuncture of Zusanli (ST36) acupoints in streptozotocin-induced rats with diabetes
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM1339443 Mock skeletal muscle strain: Wistar age: 8-10 week-old gender: Male 137.2652
GSM1339444 EA (electroacupuncture) skeletal muscle strain: Wistar age: 8-10 week-old gender: Male 124.046

ID GSE58456
Title Affymetrix Chip Data of the Transcriptome of the Rheumatoid Arthritis Rat Model Treated with Acupuncture (Affymetrix, mRNA, batch 2)
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM1693996 Peripheral blood mononuclear cells from NORA before therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 11.4742852105
GSM1693997 Peripheral blood mononuclear cells from NORA before therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 8.643228732
GSM1693998 Peripheral blood mononuclear cells from NORA before therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 112.406406085
GSM1693999 Peripheral blood mononuclear cells from RA before therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy 7.964884810500001
GSM1694000 Peripheral blood mononuclear cells from RA before therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy 7.8570905695
GSM1694001 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 12.1057932835
GSM1694002 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 12.89377954
GSM1694003 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 42.015061185
GSM1694004 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 5.080174741
GSM1694005 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 8.626030165
GSM1694006 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 5.542792634
GSM1694007 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 14.7726430525
GSM1694008 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 29.7440519805
GSM1694009 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 10.796115069999999

ID GSE58460
Title Rheumatoid Arthritis Rat Model Treated with Acupuncture
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM1165929 RAT_NORA_T0_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy 3.051784749
GSM1165930 RAT_NORA_T0_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy 2.889991952
GSM1165931 RAT_RA_T0_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy 2.977884128
GSM1165932 RAT_RA_T0_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy 2.9248314215
GSM1165933 RAT_NORA_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy 2.921039984
GSM1165934 RAT_NORA_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy 3.0290862325
GSM1165935 RAT_AP_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy 3.3799351355000002
GSM1165936 RAT_AP_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy 2.9008793495000003
GSM1165937 RAT_MTX_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy 2.7825514165
GSM1165938 RAT_MTX_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy 2.8726837485
GSM1165939 RAT_ANE_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy 2.962507473
GSM1165940 RAT_ANE_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy 2.948767312
GSM1165941 RAT_PLA_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy 2.8206212204999996
GSM1165942 RAT_PLA_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy 3.0630996535
GSM1165943 RAT_NORA_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy 2.8739680859999996
GSM1165944 RAT_NORA_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy 2.8615072075
GSM1165945 RAT_AP_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy 2.901776211
GSM1165946 RAT_AP_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy 3.2026467629999997
GSM1165947 RAT_MTX_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy 3.0443306265
GSM1165948 RAT_MTX_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy 2.8969714189999998
GSM1165949 RAT_ANE_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy 2.9576251855000004
GSM1165950 RAT_ANE_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy 2.9980180195
GSM1165951 RAT_PLA_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy 2.9658086705
GSM1165952 RAT_PLA_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy 2.9666398195
GSM1412003 RAT_NORA_T0_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412004 RAT_NORA_T0_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412005 RAT_RA_T0_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412006 RAT_RA_T0_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412007 RAT_NORA_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412008 RAT_NORA_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412009 RAT_AP_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412010 RAT_AP_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412011 RAT_MTX_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412012 RAT_MTX_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412013 RAT_ANE_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412014 RAT_ANE_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412015 RAT_PLA_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412016 RAT_PLA_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412017 RAT_NORA_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412018 RAT_NORA_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412019 RAT_AP_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412020 RAT_AP_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412021 RAT_MTX_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412022 RAT_MTX_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412023 RAT_ANE_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412024 RAT_ANE_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412025 RAT_PLA_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412026 RAT_PLA_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412027 RAT_RA_T0_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412028 RAT_RA_T0_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412029 RAT_AP_1h_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412030 RAT_AP_1h_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412031 RAT_PLA_1h_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412032 RAT_PLA_1h_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412033 RAT_AP_34d_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412034 RAT_AP_34d_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412035 RAT_PLA_34d_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412036 RAT_PLA_34d_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1693996 Peripheral blood mononuclear cells from NORA before therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therap 11.4742852105
GSM1693997 Peripheral blood mononuclear cells from NORA before therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 8.643228732
GSM1693998 Peripheral blood mononuclear cells from NORA before therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 112.406406085
GSM1693999 Peripheral blood mononuclear cells from RA before therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy 7.964884810500001
GSM1694000 Peripheral blood mononuclear cells from RA before therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy 7.8570905695
GSM1694001 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 12.1057932835
GSM1694002 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therap 12.89377954
GSM1694003 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 42.015061185
GSM1694004 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 5.080174741
GSM1694005 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 8.626030165
GSM1694006 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 5.542792634
GSM1694007 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 14.7726430525
GSM1694008 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 29.7440519805
GSM1694009 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 10.796115069999999

ID GSE752
Title Halothane/Isoflurane Repetitive Exposures
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM5082 Control 1 136.23333333333332
GSM5084 Control 2 126.10000000000001
GSM5085 Control 3 127.73333333333333
GSM5086 Control 4 158.26666666666668
GSM5087 Control 5 133.06666666666666
GSM5090 Control 6 137.63333333333335
GSM5105 Control 7 150.83333333333334
GSM5106 Control 8 149.86666666666667
GSM5107 Control 9 146.1
GSM5108 Halothane 10 exposure-1 167.63333333333333
GSM5109 Halothane 10 exposures-2 123.63333333333333
GSM5110 Halothane 10 exposures-3 112.96666666666665
GSM5111 Halothane 5 exposures-1 158.56666666666666
GSM5112 Halothane 5 exposures-2 126.86666666666667
GSM5113 Halothane 5 exposures-3 123.93333333333332
GSM5114 Isoflurane 10 exposures-1 129.79999999999998
GSM5115 Isoflurane 10 exposures-2 171.69999999999996
GSM5116 Isoflurane 10 exposures-3 108.7
GSM5117 Isoflurane 5 exposures-1 159.16666666666666
GSM5118 Isoflurane 5 exposures-2 169.66666666666666
GSM5119 Isoflurane 5 exposures-3 123.33333333333333
GSM11379 Control 10 142.86666666666667
GSM11380 Control 11 94.09999999999998
GSM11381 Control 12 133.03333333333333

ID GSE8911
Title Skeletal muscle after fine needle stimulation
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM225891 Skeletal muscle sample from fine needle-stimulated hindlimb Strain: Lewis, Gender: Male, Body Weight: 275g, Tissue: Skeletal muscle sample from fine nnedle-stimulated hindlimb 1.2572094999999999
GSM225892 Skeletal muscle sample from control hindlimb Strain: Lewis, Gender: Male, Body weight: 275g, Tissue: skeletal muscle sample from non fine needle-stimulated hindlimb 3.893055